Yahoo Web Search

  1. Ad
    related to MERCK & CO., INC
  1. PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.

  2. AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails

    Zacks via Yahoo FinanceAug 30 14:21 PM

    AbbVie, Inc. ABBV announced that it is discontinuing development of its small-cell lung cancer (SCLC) candidate rovalpituzumab tesirine or Rova-T after failure of the third study, MERU ...

  3. Top Analyst Reports: Amazon, Merck, PepsiCo & More

    Zacks via Yahoo FinanceSep 03 4:59 AM

    Rapid adoption of Prime driven by customer benefits and strengthening grocery services is aiding the top line. Further, expanding content portfolio is encouraging Prime membership. Further, ...

  4. AstraZeneca's Lupus Drug Meets Primary Endpoint in Study

    Zacks via Yahoo FinanceAug 30 15:16 PM

    AstraZeneca PLC AZN announced positive top-line results from the second phase III study on its human monoclonal antibody anifrolumab, currently under development for treating adult patients ...

  5. Esperion's Drugs in Review Hold Potential, Funds a Concern

    Zacks via Yahoo FinanceAug 26 15:05 PM

    We issued an updated research report on Esperion Therapeutics ESPR on Aug 23. Data from the phase III study evaluating bempedoic acid/Zetia combination pill showed that the combination regimen ...

  6. Forget Pfizer, Add These Big Drugmakers to Your Portfolio

    Zacks via Yahoo FinanceAug 29 13:06 PM

    Pfizer PFE, one of the biggest drugmakers in the world, is witnessing tough times in 2019. Pfizer has a Zacks Rank #5 (Strong Sell). Its earnings estimates have declined 1.7% for 2019 and 11.5% ...

  7. Why Merck (MRK) is a Top Dividend Stock for Your Portfolio

    Zacks via Yahoo FinanceAug 29 13:15 PM

    A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent ...

  8. AstraZeneca PLC AZN announced that it has secured an approval from China for the label expansion of its marketed drug Tagrisso (osimertinib) for the first-line treatment of adult patients with ...

  9. Par Pharmaceutical, Inc., Endo's operating company, expects to distribute the product through specialty pharmacies beginning this month.

  10. Bristol-Myers Announces Sale of Celgene's Otezla to Amgen

    Zacks via Yahoo FinanceAug 27 12:05 PM

    Bristol-Myers Squibb Company BMY announced that Celgene Corporation CELG has inked an agreement to sell its plaque psoriasis and psoriatic arthritis drug, Otezla, to Amgen AMGN. The deal is ...

  1. Ads
    related to MERCK & CO., INC